ArticleInternational journal of cancer2012

Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.

Ajaikumar B Kunnumakkara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.